Could early vasopressin save more lives in septic shock?

NCT ID NCT07255378

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study watches how doctors use vasopressin, a second blood pressure drug, in adults with septic shock in the ICU. It aims to see if starting it earlier lowers death rates and helps protect kidney function. Researchers will track 1,200 patients to gather real-world data.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEPTIC SHOCK are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Consorci Sanitari de Terrassa

    RECRUITING

    Terrassa, BARCELONA, 08227, Spain

  • Hospital General Universitario Gregorio Marañón

    RECRUITING

    Madrid, Madrid, 28007, Spain

  • Hospital Universitario Clínico San Carlos

    RECRUITING

    Madrid, Madrid, 28040, Spain

  • Hospital Universitario Doce de Octubre

    RECRUITING

    Madrid, Madrid, 28041, Spain

  • Hospital Universitario La Paz

    RECRUITING

    Madrid, Madrid, 28046, Spain

  • Hospital Universitario La Princesa

    RECRUITING

    Madrid, Madrid, 28006, Spain

  • Hospital Universitario Miguel Servet

    RECRUITING

    Zaragoza, ZARAGOZA, 50009, Spain

  • Hospital Universitario Puerta de Hierro

    RECRUITING

    Majadahonda, Madrid, 28222, Spain

  • Hospital Universitario Ramón y Cajal

    RECRUITING

    Madrid, Madrid, 28034, Spain

  • Hospital Universitario Rey Juan Carlos

    RECRUITING

    Móstoles, Madrid, 28933, Spain

  • Hospital Universitario de Getafe

    RECRUITING

    Getafe, Madrid, 28905, Spain

  • Hospital Universitario y Politécnico de La Fe

    RECRUITING

    Valencia, Valencia, 46026, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.